INSMED INC Amortization of Debt Issuance Costs
INSMED INC (INSM) reported Amortization of Debt Issuance Costs of $1.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- INSMED INC amortization of debt issuance costs for the quarter ending 2026-06-30 was $1.43M, a 14.74% decline year-over-year.
- INSMED INC amortization of debt issuance costs for the quarter ending 2026-03-31 was $1.38M, a 24.15% decline year-over-year.
- INSMED INC amortization of debt issuance costs for the quarter ending 2025-12-31 was $1.38M, a 21.28% decline year-over-year.
- INSMED INC amortization of debt issuance costs for the quarter ending 2025-09-30 was $1.34M, a 9.63% decline year-over-year.
- INSMED INC amortization of debt issuance costs for fiscal 2025 was $6.22M, a 9.70% decline from fiscal 2024.
- INSMED INC amortization of debt issuance costs for fiscal 2024 was $6.88M, a 5.96% decline from fiscal 2023.
- INSMED INC amortization of debt issuance costs for fiscal 2023 was $7.32M, a 83.41% increase from fiscal 2022.
- INSMED INC amortization of debt issuance costs for fiscal 2022 was $3.99M, a 111.16% increase from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.43M 10-Q · filed 2026-08-06 | $2.81M 10-Q · filed 2026-08-06 | $4.19M derived: sum of 3 quarters · filed 2026-08-06 | $5.53M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.38M 10-Q · filed 2026-05-07 | $2.76M derived: sum of 2 quarters · filed 2026-05-07 | $4.10M derived: sum of 3 quarters · filed 2026-05-07 | $5.78M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $2.72M derived: sum of 2 quarters · filed 2026-02-19 | $4.39M derived: sum of 3 quarters · filed 2026-08-06 | $6.22M 10-K · filed 2026-02-19 |
| 2025-09-30 | $1.34M 10-Q · filed 2025-10-30 | $3.02M derived: sum of 2 quarters · filed 2026-08-06 | $4.84M 10-Q · filed 2025-10-30 | $6.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.68M 10-Q · filed 2026-08-06 | $3.50M 10-Q · filed 2026-08-06 | $5.25M derived: sum of 3 quarters · filed 2026-08-06 | $6.73M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.82M 10-Q · filed 2026-05-07 | $3.57M derived: sum of 2 quarters · filed 2026-05-07 | $5.05M derived: sum of 3 quarters · filed 2026-05-07 | $6.86M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.23M derived: sum of 2 quarters · filed 2026-02-19 | $5.03M derived: sum of 3 quarters · filed 2026-02-19 | $6.88M 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.49M 10-Q · filed 2025-10-30 | $3.29M derived: sum of 2 quarters · filed 2025-10-30 | $5.14M 10-Q · filed 2025-10-30 | $6.89M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $1.80M 10-Q · filed 2025-08-07 | $3.65M 10-Q · filed 2025-08-07 | $5.40M derived: sum of 3 quarters · filed 2026-02-19 | $7.24M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $1.85M 10-Q · filed 2025-05-08 | $3.60M derived: sum of 2 quarters · filed 2026-02-19 | $5.44M derived: sum of 3 quarters · filed 2026-02-19 | $7.45M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $3.59M derived: sum of 2 quarters · filed 2026-02-19 | $5.60M derived: sum of 3 quarters · filed 2026-02-19 | $7.32M 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.84M 10-Q · filed 2024-10-31 | $3.84M derived: sum of 2 quarters · filed 2024-10-31 | $5.57M 10-Q · filed 2024-10-31 | $7.09M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $2.00M 10-Q · filed 2024-08-08 | $3.73M 10-Q · filed 2024-08-08 | $5.25M derived: sum of 3 quarters · filed 2025-02-20 | $6.08M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $1.72M 10-Q · filed 2024-05-09 | $3.25M derived: sum of 2 quarters · filed 2025-02-20 | $4.07M derived: sum of 3 quarters · filed 2025-02-20 | $4.89M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $2.35M derived: sum of 2 quarters · filed 2025-02-20 | $3.17M derived: sum of 3 quarters · filed 2025-02-20 | $3.99M 10-K · filed 2025-02-20 |
| 2022-09-30 | $822.00K 10-Q · filed 2023-10-26 | $1.64M derived: sum of 2 quarters · filed 2023-10-26 | $2.46M 10-Q · filed 2023-10-26 | $3.01M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $821.00K 10-Q · filed 2023-08-03 | $1.64M 10-Q · filed 2023-08-03 | $2.19M derived: sum of 3 quarters · filed 2024-02-22 | $2.73M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $822.00K 10-Q · filed 2023-05-04 | $1.36M derived: sum of 2 quarters · filed 2024-02-22 | $1.91M derived: sum of 3 quarters · filed 2024-02-22 | $2.36M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $542.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $1.08M derived: sum of 2 quarters · filed 2024-02-22 | $1.54M derived: sum of 3 quarters · filed 2024-02-22 | $1.89M 10-K · filed 2024-02-22 |
| 2021-09-30 | $541.00K 10-Q · filed 2022-10-27 | $998.00K derived: sum of 2 quarters · filed 2022-10-27 | $1.35M 10-Q · filed 2022-10-27 | $1.70M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $457.00K 10-Q · filed 2022-08-04 | $807.00K 10-Q · filed 2022-08-04 | $1.16M derived: sum of 3 quarters · filed 2023-02-23 | $1.51M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $350.00K 10-Q · filed 2022-05-05 | $699.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.05M derived: sum of 3 quarters · filed 2023-02-23 | $1.40M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $699.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.05M derived: sum of 3 quarters · filed 2023-02-23 | $1.40M 10-K · filed 2023-02-23 |
| 2020-09-30 | $350.00K 10-Q · filed 2021-10-28 | $699.00K derived: sum of 2 quarters · filed 2021-10-28 | $1.05M 10-Q · filed 2021-10-28 | $1.40M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | $349.00K 10-Q · filed 2021-08-05 | $698.00K 10-Q · filed 2021-08-05 | $1.05M derived: sum of 3 quarters · filed 2022-02-17 | $1.40M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | $349.00K 10-Q · filed 2021-05-06 | $699.00K derived: sum of 2 quarters · filed 2022-02-17 | $1.05M derived: sum of 3 quarters · filed 2022-02-17 | $1.40M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $699.00K derived: sum of 2 quarters · filed 2022-02-17 | $1.05M derived: sum of 3 quarters · filed 2022-02-17 | $1.40M 10-K · filed 2022-02-17 |
| 2019-09-30 | $349.00K 10-Q · filed 2020-10-29 | $698.00K derived: sum of 2 quarters · filed 2020-10-29 | $1.05M 10-Q · filed 2020-10-29 | $1.40M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $349.00K 10-Q · filed 2020-08-06 | $698.00K 10-Q · filed 2020-08-06 | $1.05M derived: sum of 3 quarters · filed 2021-02-25 | $1.46M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $349.00K 10-Q · filed 2020-04-30 | $699.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.11M derived: sum of 3 quarters · filed 2021-02-25 | $1.40M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $765.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.05M derived: sum of 3 quarters · filed 2021-02-25 | $1.35M 10-K · filed 2021-02-25 |
| 2018-09-30 | $415.00K 10-Q · filed 2019-10-30 | $701.00K derived: sum of 2 quarters · filed 2019-10-30 | $1.00M 10-Q · filed 2019-10-30 | $1.03M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $286.00K 10-Q · filed 2019-08-01 | $585.00K 10-Q · filed 2019-08-01 | $612.00K derived: sum of 3 quarters · filed 2020-02-25 | $642.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $299.00K 10-Q · filed 2019-05-07 | $326.00K derived: sum of 2 quarters · filed 2020-02-25 | $356.00K derived: sum of 3 quarters · filed 2020-02-25 | $386.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $57.00K derived: sum of 2 quarters · filed 2020-02-25 | $87.00K derived: sum of 3 quarters · filed 2020-02-25 | $118.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $30.00K 10-Q · filed 2018-10-30 | $60.00K derived: sum of 2 quarters · filed 2018-10-30 | $91.00K 10-Q · filed 2018-10-30 | $122.00K derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $30.00K 10-Q · filed 2018-08-02 | $61.00K 10-Q · filed 2018-08-02 | $92.00K derived: sum of 3 quarters · filed 2019-02-22 | |
| 2017-03-31 | $31.00K 10-Q · filed 2018-05-02 | $62.00K derived: sum of 2 quarters · filed 2019-02-22 | ||
| 2016-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $281.00K 10-K · filed 2019-02-22 | ||
| 2016-09-30 | $250.00K 10-Q · filed 2017-11-02 | |||
| 2015-12-31 | $458.00K 10-K · filed 2018-02-23 | |||
| 2014-12-31 | $390.00K 10-K · filed 2017-02-23 | |||
| 2012-09-30 | $55.00K 10-Q · filed 2012-11-07 | |||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |